EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.34 | additional information | LpL is regulated by feeding/fasting and muscle contraction, insulin stimulates LpL by increasing the level of LpL mRNA and regulating LpL activity through both posttranscriptional and posttranslational mechanisms | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.34 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.1.34 | adipocyte | - |
Homo sapiens | - |
3.1.1.34 | heart | - |
Homo sapiens | - |
3.1.1.34 | liver | LpL is present in the liver during fetal and early postnatal life, but is then suppressed by a putative transcriptional regulatory mechanism | Homo sapiens | - |
3.1.1.34 | mammary gland | in the mammary gland, synthesis of LpL is induced during late pregnancy and lactation | Homo sapiens | - |
3.1.1.34 | vascular endothelium | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.34 | triacylglycerol + H2O | - |
Homo sapiens | diacylglycerol + a carboxylate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.1.34 | LPL | - |
Homo sapiens |